Feel free to contact us if you have any questions or a specific inquiry.
Medical Implants Company hired Successor to retiring CEO Amidst Strategic Relocation and Organizational Change
Client Description
Our client is a family-owned medical device manufacturer with a 100+ year legacy, headquartered in the D-A-CH region. The company develops and distributes implantable medical devices, surgical instruments, and high-margin consumables. With operations in nearly 100 countries and global revenues exceeding $100 million, the U.S. business contributes roughly one-third of total revenue and the majority of global EBIT. The medium-term strategic objective included increasing U.S. revenue by 20%.
Historically, U.S. operations were based in a Midwestern city known for its reputable medical school and teaching hospital. However, structural changes in the U.S. healthcare system and shifting market dynamics led to the Dallas–Fort Worth area emerging as a more advantageous hub for growth, customer proximity, and logistics. While most staff remained in the Midwest, the planned relocation presented both operational challenges and an opportunity to rejuvenate a team of approximately 50 FTEs.
Challenge
In order to attain their sales goals, the company decided to relocate their US HQ to Texas to be closer to target clientele and distributors and to optimize logistics. At the same time, their CEO was planning to retire and was already working part-time. TH Bender was retained to recruit a commercially and sales minded COO with path to succeed the soon-to-retire CEO after a period of transition.
TH Bender was retained to recruit a commercially minded Chief Operating Officer with a strong sales and operational background and the potential to transition into the CEO role within 12 months. The ideal candidate needed to demonstrate:
- Experience in direct sales and industry-specific influencer networks
- P&L responsibility within a business unit or full operation
- Familiarity with the implantable device space, traditionally centered in Southern California (and not in Texas)
- Strong relationships with medical procurement networks, such as Group purchasing organizations (GPOs), including Integrated Delivery Networks (IDNs) and hospital systems
- Willingness to be based in or relocate to Texas
Solution
TH Bender leveraged its deep industry networks in life sciences and medical devices to source high-potential candidates. The firm identified a timely opportunity: two of the client’s key competitors were undergoing a merger, which was expected to lead to structural redundancies.
By maintaining strong market intelligence and discreet outreach, TH Bender identified a standout candidate affected by the merger—someone with the exact commercial and operational profile the client required. In addition to a solid leadership background and proven success in scaling commercial operations, the candidate brought extensive experience working with U.S. hospital purchasing groups, IDNs, and procurement networks—a key asset to accelerate U.S. growth.
The role offered a compelling career path that aligned with the candidate’s aspirations and professional background.
Looking for a first-class interim executive? Contact us for availability
Results
The candidate was hired as COO and, after a planned 12-month transition period, successfully assumed the role of Chief Executive Officer. As the U.S. operations moved to Texas, the team was scaled up with new hires, replacing legacy staff who opted not to relocate. The transition was smooth, and the company is now well-positioned to meet its U.S. growth targets under new leadership.
Related assignments
-
Hidden Champion Sawing Technology
Led Executive Turnaround as Interim COO: CEO Replacement, Full Restructuring, and Market Reboot
-
From $50M Fine to Turnaround – An American Leads the Way in Bavaria
Led Executive Turnaround as Interim COO: CEO Replacement, Full Restructuring, and Market Reboot
-
Building a U.S. Growth Story for a German Clean Tech Venture
Led Executive Turnaround as Interim COO: CEO Replacement, Full Restructuring, and Market Reboot